Bevacizumab, Docetaxel, and Gemcitabine Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
This study is ongoing, but not recruiting participants.
Sponsor:
Nathan Pennell, MD, PhD
Collaborator:
Information provided by (Responsible Party):
Nathan Pennell, MD, PhD, Case Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT00970684
First received: September 1, 2009
Last updated: February 6, 2013
Last verified: February 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | November 2013 |
| Primary Completion Date: | September 2011 (Final data collection date for primary outcome measure) |